Project Grant HT9425261E045
Award Date 4/1/26
Completion Date 3/31/29
Dollars Obligated $1.2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Bronx, NY 10461, USA
Similar Awards
- Federal Grant Award Summary Albert Einstein College of Medicine received a $1.25 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective April 1, 2026, through March 31, 2029. The project, titled "Unraveling Immunosuppressive Mechanisms in Breast Cancer Stem Cells for New Immunotherapy," involves research activities conducted at the institution's facility in Bronx, NY. This three-year award...
- Federal Grant Award Summary Albert Einstein College of Medicine received a $1.344 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective May 1, 2025, through April 30, 2029. The award supports research on targeting noncanonical Wnt signaling to prevent Ewing sarcoma metastases utilizing a novel zebrafish model. This research addresses a critical cancer biology challenge relevant to military medical...
- Federal Grant Award Summary Albert Einstein College of Medicine received a $672,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2027. The award supports research investigating a novel synthetic lethal vulnerability in anaplastic thyroid cancer through inhibition of one-carbon metabolism. This two-year research initiative will be conducted at the institution's...
- The Albert Einstein College of Medicine, a private non-profit educational institution in the Bronx, New York, has been awarded a $672,000 Project Grant by the Defense Health Agency, a component of the Department of Defense. The grant, which runs from March 1, 2024 to February 29, 2028, is funded under the Military Medical Research and Development program (CFDA 12.420) and will support research on "Clonal Hematopoiesis as a Driver of Therapeutic Resistance and Metastatic Relapse in Breast...
- Federal Grant Award Summary Albert Einstein College of Medicine received a $3.29M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to support the production of cultured red blood cells for sickle cell disease patient support. The award, effective June 1, 2025 through May 31, 2029, represents a four-year research initiative focused on developing biomedical solutions relevant to military personnel and the broader public...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Icahn School of Medicine at Mount Sinai a Project Grant totaling $633,750 under the Military Medical Research and Development program (CFDA 12.420) for the period August 1, 2025, through July 31, 2028. The award supports research investigating the interplay between sensory neurons and natural killer (NK) cells during breast cancer metastatic dormancy. This three-year project advances the DHA's mission to transform healthcare for...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded Icahn School of Medicine at Mount Sinai a $633,750 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025, through July 31, 2028. This award supports research investigating the interplay between sensory neurons and natural killer (NK) cells during breast cancer metastatic dormancy. The research aims to advance understanding of mechanisms that suppress breast...
- The Defense Health Agency awarded a $462,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Albert Einstein College of Medicine in Bronx, NY. This grant, with a period of performance from January 1, 2025 to December 31, 2026, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the grant will fund research on the "Proteomics of Vascular Wall...
- The Albert Einstein College of Medicine was awarded a $1,260,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award will support research into "A NOVEL IMMUNE CHECKPOINT PATHWAY IN HUMAN PROSTATE CANCER" from July 1, 2022 to June 30, 2025. The Military Medical Research and Development program aims to transform health care for service members and the public through innovative...
- The U.S. Department of Defense's Defense Health Agency awarded a $672,000 Project Grant to the Albert Einstein College of Medicine in Bronx, NY to support the "MRNA TRANSLATION AND IMMUNE RECOGNITION IN MYC-DRIVEN LYMPHOMA" research project. This grant is funded under the Military Medical Research and Development (CFDA 12.420) program, which supports advanced biomedical research initiatives to transform healthcare for military service members and the broader public. The 2-year project,...